DK3087984T3 - Profylaktisk og terapeutisk middel mod forstyrrelser af opmærksomhed, aktivitet og impulsitivitet (adhd) - Google Patents

Profylaktisk og terapeutisk middel mod forstyrrelser af opmærksomhed, aktivitet og impulsitivitet (adhd) Download PDF

Info

Publication number
DK3087984T3
DK3087984T3 DK14875426.0T DK14875426T DK3087984T3 DK 3087984 T3 DK3087984 T3 DK 3087984T3 DK 14875426 T DK14875426 T DK 14875426T DK 3087984 T3 DK3087984 T3 DK 3087984T3
Authority
DK
Denmark
Prior art keywords
impulsivity
adhd
prophylactic
attention
activity
Prior art date
Application number
DK14875426.0T
Other languages
English (en)
Inventor
Hiroko Togashi
Sachiko Hirade
Fumio Yoneda
Kazue Takahata
Original Assignee
Fujimoto Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Co Ltd filed Critical Fujimoto Co Ltd
Application granted granted Critical
Publication of DK3087984T3 publication Critical patent/DK3087984T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14875426.0T 2013-12-25 2014-12-15 Profylaktisk og terapeutisk middel mod forstyrrelser af opmærksomhed, aktivitet og impulsitivitet (adhd) DK3087984T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013266498 2013-12-25
PCT/JP2014/083100 WO2015098591A1 (ja) 2013-12-25 2014-12-15 注意欠如・多動性障害の予防および治療剤

Publications (1)

Publication Number Publication Date
DK3087984T3 true DK3087984T3 (da) 2021-06-14

Family

ID=53478455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14875426.0T DK3087984T3 (da) 2013-12-25 2014-12-15 Profylaktisk og terapeutisk middel mod forstyrrelser af opmærksomhed, aktivitet og impulsitivitet (adhd)

Country Status (14)

Country Link
US (1) US9782383B2 (da)
EP (1) EP3087984B1 (da)
JP (1) JP6518397B2 (da)
KR (1) KR102280552B1 (da)
CN (1) CN106163514B (da)
AU (1) AU2014371437B2 (da)
BR (1) BR112016014236A2 (da)
CA (1) CA2932301A1 (da)
DK (1) DK3087984T3 (da)
ES (1) ES2864669T3 (da)
IL (1) IL246872B (da)
RU (1) RU2708694C2 (da)
SI (1) SI3087984T1 (da)
WO (1) WO2015098591A1 (da)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2267190T3 (es) 1997-08-07 2007-03-01 Fujimoto Brothers Co., Ltd. Derivados de etilamina novedosos.
US6210705B1 (en) 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
DE19934592C2 (de) 1999-07-23 2003-10-23 Benckiser Nv Vorrichtung zur Aufnahme und dosierten Abgabe einer aktiven Zusammensetzung in eine Waschmaschine, einen Wäschetrockner oder eine Geschirrspülmaschine
JP4953040B2 (ja) 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤
JP5030194B2 (ja) 2004-11-25 2012-09-19 国立大学法人九州大学 薬物依存症治療剤
EP1905760B1 (en) 2005-06-28 2011-10-26 Fujimoto Co., Ltd. Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate
WO2008095221A1 (en) * 2007-02-07 2008-08-14 Gosforth Centre (Holdings) Pty Ltd Treatment of adhd
AU2009279372A1 (en) * 2008-08-06 2010-02-11 Gosforth Centre (Holdings) Pty Ltd Compositions and methods for treating psychiatric disorders
US8802696B2 (en) * 2009-05-12 2014-08-12 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof

Also Published As

Publication number Publication date
KR102280552B1 (ko) 2021-07-26
IL246872B (en) 2021-03-25
IL246872A0 (en) 2016-09-29
RU2708694C2 (ru) 2019-12-11
RU2016129912A (ru) 2018-01-30
CN106163514A (zh) 2016-11-23
JP6518397B2 (ja) 2019-05-22
US9782383B2 (en) 2017-10-10
US20160296495A1 (en) 2016-10-13
EP3087984B1 (en) 2021-04-07
CA2932301A1 (en) 2015-07-02
CN106163514B (zh) 2019-07-19
JPWO2015098591A1 (ja) 2017-03-23
RU2016129912A3 (da) 2018-07-06
BR112016014236A2 (pt) 2017-08-08
ES2864669T3 (es) 2021-10-14
AU2014371437B2 (en) 2020-01-30
EP3087984A1 (en) 2016-11-02
KR20160096184A (ko) 2016-08-12
SI3087984T1 (sl) 2021-08-31
EP3087984A4 (en) 2017-08-23
WO2015098591A1 (ja) 2015-07-02
AU2014371437A1 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
DK4000608T3 (da) Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf
IL240388A0 (en) Methods of treating melanoma
DK2882496T3 (da) Behandling og diagnosticering af melanom
DK2962753T3 (da) Hydrogenbehandlingskatalysator med høj densitet af molybden og fremgangsmåde til fremstilling heraf
DK3050848T3 (da) Molekylesi, fremstillingsfremgangsmåde og anvendelse deraf
DK2857039T3 (da) Terapeutisk middel eller profylaktisk middel mod demens
IL246038B (en) Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
IL243043B (en) Dynamic modification of modulation throughout a therapy period
DK2935303T3 (da) 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV
DK3039146T3 (da) Produkter og fremgangsmåder til behandling af amyotrofisk lateral sklerose
DK2861273T3 (da) Anvendelse af heparin og kulhydrater til behandling af cancer.
LT2885010T (lt) Tautopatijos gydymo būdai
DK3329909T3 (da) Fenfluramin til anvendelse i behandling af dravet syndrom
DK3432649T3 (da) Radionetværksknude, brugerindretning og fremgangsmåder dertil
HUE053615T2 (hu) Dekódoló berendezés és dekódolási eljárás
HUE057005T2 (hu) Oszlopon történõ vírusinaktiváló eljárások
DK3071248T3 (da) Vævsstilladsmateriale til vævsregenerering og fremgangsmåder til fremstilling
DK3232663T3 (da) Fremgangsmåder og anordninger til afkodning
DK2976084T3 (da) Kombination, der omfatter zidovudin og polymyxin
HUE050485T2 (hu) Tauopathia kezelési módszerei
DK3089707T3 (da) Vævtransplantater og fremgangsmåder til fremstilling og brug af samme
DK3074544T3 (da) Martensitholdigt rustfrit stål, stykke udført i dette stål og fremgangsmåde til fremstilling heraf
DK3131673T3 (da) Fremgangsmåde til fornyelse af hydrogenbehandlingskatalysator
DK3389669T3 (da) Triterpensaponinvarianter, syntesefremgangsmåder og anvendelse deraf
DK3056272T3 (da) Betamolekylærsi, fremstillingsfremgangsmåde dertil og hydrogeneringskatalysator dermed